Validated novel therapeutic targets and drugs for the treatment of obesity - Biowebspin | Biowebspin
Logo Biowebspin

Biowebspin : THE #1 ACADEMIA-INDUSTRY PARTNERING NETWORK FOR SCIENTIFIC INNOVATIONS

The worldwide platform to find industrial partners and funding

External open innovation partner programValidated novel therapeutic targets and drugs for the treatment of obesity
Have you identified novel therapeutic targets or drugs for the treatment of obesity? Are you interested in partnering with a top pharma company to translate your new science into a new medicine?
What we are looking for

We are looking for new treatment opportunities for obesity which translate in efficacious body weight lowering. We are interested in mechanisms inducing negative energy balance such as mechanisms influencing food intake, food preference, futile cycling (but no mitochondrial uncoupling), but also bariatric surgery mimetics, energy expenditure increasing mechanisms (including browning).
In vitro and ideally also in vivo data demonstrating these new concepts are highly desirable.

What we offer and how does it work

Our company has an existing portfolio in obesity both preclinical and clinical and is therefore an experienced partner in this field. All proposals will be assessed by our Research & Development team. Based on the level of interest within the Company research portfolio and strategic fit, we will enter into discussion with selected candidate(s), potentially leading to partnership agreements or collaborations.

Proponents that submit proposals of interest will be contacted within 8 weeks of submission to clarify additional details.

What to submit

Submit a proposal in a form which is available online (it takes about 15 minutes).The proposal should be brief, sufficient to provide the main body of the proposal and its innovativeness. The applicant should also provide information about his or her critical knowledge that is applicable for the proposal, and how the knowledge could be supplemented (i.e., what is additionally required to complete the project). The applicants are strongly encouraged to give us additional information including references or other materials to facilitate the evaluation process.

Privacy, confidentiality & FAQ

The Company will not share the information beyond its own staff; your initial proposal should contain only non-confidential information.
If your proposal is selected, the Company is open to complete a Confidentiality Disclosure Agreement (CDA).

Biowebspin

Biowebspin pays a lot of attention to the privacy, intellectual property, confidentiality and security of its member data.</p> <p>Biowebspin is a matchmaking platform between academia & industry. Biowebspin is not involved in the IP discussion and is not charging any success or license fees. Your «Open Innovation» opportunities on Biowebspin are only visible by industrials and the Biowebspin team. You can remove your data at any time. Biowebspin strongly recommends that you do not enter any confidential data or if you do so, that your technology transfer office agrees the submission of your pre-proposal on Biowebspin. If you directly submit your pre-proposal on an industrial partner website, you will agree their terms, conditions and privacy policy of our industrial partner website. Biowebspin is not responsible for the content, accuracy, or opinion of its industrial partner website. As a Swiss International company, Biowebspin has high standard security and privacy system. Biowebspin is in accordance with the Federal Data Protection and Information Commissioner. Contact us for more information about the terms and conditions of the matchmaking service of Biowebspin.